Founded in Eden Prairie, United States, Surmodics, Inc. is a leading provider of advanced technologies in surface modification, drug delivery, and in vitro diagnostics for the healthcare industry. The company's core mission is to enhance medical device performance and improve patient outcomes through innovative solutions. Surmodics offers products such as the Sublime™ Radial Access Platform for lower extremity treatments, the Pounce™ Arterial Thrombectomy System, and Preside™ Hydrophilic Coatings designed for navigating complex anatomical pathways. Their market focus spans neuro, coronary, and peripheral medical applications.
Surmodics has garnered attention from notable investors and industry leaders due to its pioneering contributions to healthcare technology. Key achievements include the development of cutting-edge coating solutions that drive value and efficiency in medical devices. The company's impact is evident in its ability to set new standards in medical treatments and device performance, significantly benefiting healthcare providers and patients alike.
